Immunotherapy comes in many forms — treatment vaccines, antibody therapies and drugs — and can be received through an injection, a pill or capsule, a topical ointment or cream, or a catheter.
This approach, however, has its downsides too, with the first being the high price of new immunotherapy drugs.
Some estimates suggest that checkpoint inhibitor treatments could cost as much as Sh100 million per patient.
A boost to your immune system could be all you need to cure cancer, if new developments in the US are anything to go by.
America’s Food and Drug Administration has approved an immunotherapy drug, called Keytruda, which stimulates the body’s immune system, for the first-line treatment of patients with metastatic, non-small-cell lung cancer.
